Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Diagnostic Microbiology and Infectious Disease
|
July 3, 2014
How severe is antibiotic pharmacokinetic variability in critically ill patients and what can be done about it?
T W Felton, W W Hope, J A Roberts
Anaesthesia
|
January 18, 2006
Life-threatening pulmonary hypertension and right ventricular failure complicating calcium and phosphate replacement in the intensive care unit
T W Felton, B A McCormick, S R Finfer, et al.
The Journal of Antimicrobial Chemotherapy
|
February 1, 2018
Comparison of piperacillin exposure in the lungs of critically ill patients and healthy volunteers
T W Felton, K Ogungbenro, E Boselli, et al.
Journal of the Intensive Care Society
|
August 27, 2019
Non-directed bronchial lavage is a safe method for sampling the respiratory tract in critically ill patient
B V Bonvento, J A Rooney, M O Columb, et al.
Clinical Pharmacology and Therapeutics
|
June 14, 2014
Pulmonary penetration of piperacillin and tazobactam in critically ill patients
T W Felton, K McCalman, I Malagon, et al.
The Journal of Antimicrobial Chemotherapy
|
September 26, 2018
Impact of a diagnostics-driven antifungal stewardship programme in a UK tertiary referral teaching hospital
R Rautemaa-Richardson, V Rautemaa, F Al-Wathiqi, et al.
Antimicrobial Agents and Chemotherapy
|
May 7, 2014
Individualization of piperacillin dosing for critically ill patients: dosing software to optimize antimicrobial therapy
T W Felton, J A Roberts, T P Lodise, et al.
Antimicrobial Agents and Chemotherapy
|
May 16, 2012
Population pharmacokinetics of extended-infusion piperacillin-tazobactam in hospitalized patients with nosocomial infections
T W Felton, W W Hope, B M Lomaestro, et al.
Antimicrobial Agents and Chemotherapy
|
September 5, 2013
Impact of Bolus dosing versus continuous infusion of Piperacillin and Tazobactam on the development of antimicrobial resistance in Pseudomonas aeruginosa
T W Felton, J Goodwin, L O'Connor, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
April 7, 2018
Invasive pulmonary aspergillosis is associated with adverse clinical outcomes in critically ill patients receiving veno-venous extracorporeal membrane oxygenation
I Rodriguez-Goncer, S Thomas, P Foden, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Diagnostic Microbiology and Infectious Disease
|
July 3, 2014
How severe is antibiotic pharmacokinetic variability in critically ill patients and what can be done about it?
T W Felton, W W Hope, J A Roberts
Anaesthesia
|
January 18, 2006
Life-threatening pulmonary hypertension and right ventricular failure complicating calcium and phosphate replacement in the intensive care unit
T W Felton, B A McCormick, S R Finfer, et al.
The Journal of Antimicrobial Chemotherapy
|
February 1, 2018
Comparison of piperacillin exposure in the lungs of critically ill patients and healthy volunteers
T W Felton, K Ogungbenro, E Boselli, et al.
Journal of the Intensive Care Society
|
August 27, 2019
Non-directed bronchial lavage is a safe method for sampling the respiratory tract in critically ill patient
B V Bonvento, J A Rooney, M O Columb, et al.
Clinical Pharmacology and Therapeutics
|
June 14, 2014
Pulmonary penetration of piperacillin and tazobactam in critically ill patients
T W Felton, K McCalman, I Malagon, et al.
The Journal of Antimicrobial Chemotherapy
|
September 26, 2018
Impact of a diagnostics-driven antifungal stewardship programme in a UK tertiary referral teaching hospital
R Rautemaa-Richardson, V Rautemaa, F Al-Wathiqi, et al.
Antimicrobial Agents and Chemotherapy
|
May 7, 2014
Individualization of piperacillin dosing for critically ill patients: dosing software to optimize antimicrobial therapy
T W Felton, J A Roberts, T P Lodise, et al.
Antimicrobial Agents and Chemotherapy
|
May 16, 2012
Population pharmacokinetics of extended-infusion piperacillin-tazobactam in hospitalized patients with nosocomial infections
T W Felton, W W Hope, B M Lomaestro, et al.
Antimicrobial Agents and Chemotherapy
|
September 5, 2013
Impact of Bolus dosing versus continuous infusion of Piperacillin and Tazobactam on the development of antimicrobial resistance in Pseudomonas aeruginosa
T W Felton, J Goodwin, L O'Connor, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
April 7, 2018
Invasive pulmonary aspergillosis is associated with adverse clinical outcomes in critically ill patients receiving veno-venous extracorporeal membrane oxygenation
I Rodriguez-Goncer, S Thomas, P Foden, et al.
Page
of 2